Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 416-530-4 | CAS number: 178949-82-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In a GLP study conducted according to OECD
Guideline 406 and EU Method B.6, trisodium EDDS showed no sensitising
potential to the clipped skin of guinea pigs after induction by three
weekly exposures to 50% of the test material followed two weeks later by
a 50% challenge dose (Arcelin, 1993c).
In a GLP study conducted according to a protocol similar to OECD
Guideline 406, trisodium EDDS showed no sensitising potential when
applied to the clipped skin of guinea pigs after induction by three
weekly exposures to 100% (0.5 g) of the test material followed two and
three weeks later by a 100% challenge dose (Merriman, 1995).
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 10 May to 10 June 1993
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.4100 (Skin Sensitisation)
- Deviations:
- not specified
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- In vivo test undertaken prior to 2005
- Species:
- guinea pig
- Strain:
- other: albino Himalayan spotted
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: BRL, Biological Research Laboratories Ltd., W¿lferstrasse 4, CH-4414 Fuellinsdorf, Switzerland
- Age at study initiation: 7-9 weeks
- Weight at study initiation: males, 473-565 g; females, 473-529 g
- Housing: individually in Makrolon cages on softwood bedding
- Diet (e.g. ad libitum): conventional, ad libitum
- Water (e.g. ad libitum): tap water, ad libitum (with 1 g/litre ascorbic acid added once weekly)
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3
- Humidity (%): 40-70
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12 - Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Remarks:
- bi-distilled
- Concentration / amount:
- 50%
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Remarks:
- bi-distilled
- Concentration / amount:
- 50%
- No. of animals per dose:
- 10/sex/dose treated with test substance
5/sex/dose control group - Details on study design:
- RANGE FINDING TESTS:
Induction: 2 animals of each sex were patch-tested with 5, 10, 20 and 50% of the test substance on four separate areas of the clipped skin for a 6-h exposure period.
Challenge: 2 animals of each sex were induced with 50% of the test substance and challenged with 5, 10, 20 and 50% on four separate areas of the clipped skin for a 6-h exposure period.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 3
- Exposure period: 6 h
- Test groups: 10 males and 10 females
- Control group: 5 males and 5 females
- Site: shoulder region
- Frequency of applications: every 7 days
- Duration: 6 h
- Concentration: 0 (control) or 50%
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 2 weeks after last induction exposure
- Exposure period: 6 h
- Test groups: 10 males and 10 females
- Control group: 5 males and 5 females
- Site: on area of shoulder below that used for induction
- Concentrations: 50%
- Evaluation (h after challenge): 24 and 48 h after removal of the patch
OTHER: animals were observed for signs of clinical toxicity and body weights were recorded at start of acclimatization period, on day 1 of induction and at study termination - Challenge controls:
- Negative controls (5/sex) received the challenge dose without previous induction exposure
- Positive control substance(s):
- no
- Remarks:
- Formaldehyde had been used in a separate test (25 November to 30 December 1992) to evaluate the incidence of allergic reactions in the guinea pig strain
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No evidence of local or systemic toxicity, no treatment-related deaths and no differences in body weight gain between the groups
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No evidence of local or systemic toxicity, no treatment-related deaths and no differences in body weight gain between the groups.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No evidence of local or systemic toxicity, no treatment-related deaths and no differences in body weight gain between the groups
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: No evidence of local or systemic toxicity, no treatment-related deaths and no differences in body weight gain between the groups.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No evidence of local or systemic toxicity, no treatment-related deaths and no differences in body weight gain between the groups
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 50 %. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No evidence of local or systemic toxicity, no treatment-related deaths and no differences in body weight gain between the groups.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No evidence of local or systemic toxicity, no treatment-related deaths and no differences in body weight gain between the groups
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 50 %. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No evidence of local or systemic toxicity, no treatment-related deaths and no differences in body weight gain between the groups.
- Reading:
- 1st reading
- Group:
- positive control
- Remarks on result:
- not measured/tested
- Remarks:
- Formaldehyde had been used in a separate test (25 November to 30 December 1992) to evaluate the incidence of allergic reactions in the guinea pig strain
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In a GLP study conducted according to OECD Guideline 406 and EU Method B.6, trisodium EDDS showed no sensitising potential to the clipped skin of guinea pigs after induction by three weekly exposures to 50% of the test material followed two weeks later by a 50% challenge dose (modified Buehler method).
- Executive summary:
In a GLP study conducted according to OECD Guideline 406 and EU method B.6, trisodium EDDS was assessed for its sensitisation potential when applied to the skin of albino guinea pigs (modified Buehler method).
After a range-finding study to determine the concentrations of the test substance to use, groups of ten guinea pigs of each sex were exposed to a 50% solution of the test substance for 6 h under an occluded patch applied to the clipped shoulder region, followed by two further exposures at 7-day intervals. After a 2-week recovery period, the animals were exposed to a 50% challenge dose and observed for skin reactions for 48 h. Groups of five animals of each sex were used as negative controls, receiving only the challenge dose.
There was no evidence of positive skin reactions either after the induction exposures or after the challenge dose in any of the animals. No deaths occurred during the study and no clinical signs of toxicity or effects on body weight gain were seen.
In a modified Buehler assay, trisodium EDDS showed no sensitising potential to the skin of guinea pigs after induction by three weekly exposures to 50% of the test material followed two weeks later by a 50% challenge dose. According to EU CLP regulation, trisodium EDDS would not be classified as a skin sensitiser under the conditions of this test.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 20 December 1994 to 2 February 1995
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- Relative humidity was reportedly 23-64% (OECD Guideline recommends 30-70%; this deviation is considered to have no adverse effect on the outcome of this study)
- GLP compliance:
- yes
- Type of study:
- Buehler test
- Species:
- guinea pig
- Strain:
- other: Hartley-derived albino
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Sprague Dawley Inc., Haslett, Michigan, USA
- Age at study initiation: "young adult"
- Weight at study initiation: males, 341-420 g; females, 309-379 g
- Housing: individually in stainless steel cages
- Diet (e.g. ad libitum): conventional, ad libitum
- Water (e.g. ad libitum): purified tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-23
- Humidity (%): 23-64 (OECD Guideline recommends 30-70%)
- Air changes (per hr): 10-12
- Photoperiod (hrs dark / hrs light): 12/12 - Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- Concentration of test material used for induction: Topical: 0.5 g neat in Hilltop chamber
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- Concentration of test material used for induction: Topical: 0.5 g neat in Hilltop chamber
Concentration of test material used for each challenge: 0.5 g neat in Hilltop chamber - No. of animals per dose:
- Number of animals in test group: 10/sex (1 male died on day 20 prior to the challenge phase)
Number of animals in negative control group: 5/sex
Number of animals in positive control group: 3/sex
Number of animals in postive, non-induced control group: 2/sex - Details on study design:
- RANGE FINDING TESTS:
In an initial range-finding study, two animals of each sex were topically exposed to 50, 60, 80 and 100% of the test substance under four occluded patches or in Hilltop chambers for 6 h. All animals were found dead the next day, and clinical abnormalies suggested that test substance-related toxicity may have occurred.
In a second study, two animals of each sex were treated with 100% of the test substance under an occluded Hilltop chamber for 6 h.
To determine the appropriate challenge dose two animals of each sex were topically exposed to either 50 and 75% or 25 and 100% under occluded patches or Hilltop chambers for 6 h.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 3
- Exposure period: 6 h
- Test groups: 10/sex. Test substance in Hilltop chamber (test site moistened with distilled water prior to application of test substance)
- Control group: 5/sex; no treatment
- Site: left shoulder area
- Frequency of applications: once per week for 3 weeks (days 0, 7 and 14)
- Duration: 3 weeks
- Concentrations: 100% (0.5 g as powder)
B. CHALLENGE EXPOSURE
- No. of exposures: 2
- Day(s) of challenge: days 28 and 35
- Exposure period: 6 h
- Test groups: test substance in Hilltop chamber (test site moistened with distilled water prior to application of test substance)
- Control group: test substance in Hilltop chamber (test site moistened with distilled water prior to application of test substance)
- Site: right shoulder area
- Concentrations: 100% (0.5 g as powder)
- Evaluation (hr after challenge): 24 and 48 hr after patch removal
OTHER: observations for signs of clinical toxicity; body weights taken on day 1 for the test animals and on the day prior to the challenge phases for test animals and the negative and positive control animals - Challenge controls:
- Five naive guinea pigs of each sex were exposed to the challenge dose of 0.5 g on day 28 of the study
- Positive control substance(s):
- yes
- Remarks:
- 1-chloro-2,4-dinitrobenzene, 0.5% in ethanol used for the induction phases, 0.1 and 0.2% used for the challenge. Control animals received only the challenge doses
- Positive control results:
- For erythema, the positive control scored grades of 1 in three animals and 2 in three animals at 24 h, and 1 in five animals and 2 in one animal at 48 h when exposed to 0.1%. The grades after exposure to 0.2% were 2 in two animals and 4 in four animals at both 24 and 48 h.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0.5 g
- No. with + reactions:
- 1
- Total no. in group:
- 19
- Clinical observations:
- slight but confined or moderate patchy erythema seen in one animal.
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0.5 g. No with. + reactions: 1.0. Total no. in groups: 19.0. Clinical observations: slight but confined or moderate patchy erythema seen in one animal..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.5 g
- No. with + reactions:
- 0
- Total no. in group:
- 19
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.5 g. No with. + reactions: 0.0. Total no. in groups: 19.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0.5 g
- No. with + reactions:
- 0
- Total no. in group:
- 19
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: test group. Dose level: 0.5 g. No with. + reactions: 0.0. Total no. in groups: 19.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.5 g
- No. with + reactions:
- 0
- Total no. in group:
- 19
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 0.5 g. No with. + reactions: 0.0. Total no. in groups: 19.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0.5 g
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0.5 g. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0.5 g
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0.5 g. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0.5 g
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: negative control. Dose level: 0.5 g. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0.5 g
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 0.5 g. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- other: 24 and 48 hr after challenge
- Group:
- positive control
- Dose level:
- 0.1%
- No. with + reactions:
- 6
- Total no. in group:
- 6
- Clinical observations:
- slight to moderate erythema, very slight to severe edema
- Remarks on result:
- other: Reading: other: 24 and 48 hr after challenge. Group: positive control. Dose level: 0.1%. No with. + reactions: 6.0. Total no. in groups: 6.0. Clinical observations: slight to moderate erythema, very slight to severe edema.
- Reading:
- other: 24 and 48 hr after challenge
- Group:
- positive control
- Dose level:
- 0.2%
- No. with + reactions:
- 6
- Total no. in group:
- 6
- Clinical observations:
- moderate to severe erythema, very slight to severe edema, blanching, mild eschar formation
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: other: 24 and 48 hr after challenge. Group: positive control. Dose level: 0.2%. No with. + reactions: 6.0. Total no. in groups: 6.0. Clinical observations: moderate to severe erythema, very slight to severe edema, blanching, mild eschar formation.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In a GLP study conducted according to a protocol similar to OECD Guideline 406, trisodium EDDS showed no sensitising potential when applied to the clipped skin of guinea pigs after induction by three weekly exposures to 100% (0.5 g) of the test material followed two and three weeks later by a 100% challenge dose (modified Buehler method).
- Executive summary:
In a GLP study conducted according to a protocol similar to OECD Guideline 406, trisodium EDDS was assessed for its ability to induce skin sensitisation in a Buehler assay in albino guinea pigs.
After a range-finding study, ten animals of each sex were placed in Buehler restrainers and exposed to an induction dose of 0.5 g of trisodium EDDS in an occluded Hilltop chamber for 6 h. The induction process was repeated 7 and 14 d later. After a further 14 d the treated animals and an untreated control group (5/sex) received a challenge dose of 0.5 g for 6 h. The test sites were scored for erythema and edema 24 and 48 h after patch removal. The test sites were rechallenged 7 d later.
One animal in the treatment group showed slight confluent erythema 24 h after challenge application; all other animals in this group as well as the control group showed no reaction or slight patchy erythema at 24 and 48 h post challenge. The positive controls developed moderate to severe erythema demonstrating the validity of the study. One animal in the treatment group died on day 20 (prior to the challenge phase) from undetermined causes; all other animals remained healthy and gained in body weight throughout the study.
In conclusion, trisodium EDDS exhibited no evidence of a skin sensitising potential when tested at 100% (0.5 g) in a Buehler sensitisation assay in guinea pigs. According to EU CLP regulation, trisodium EDDS would not be classified as a skin sensitiser under the conditions of this test.
Referenceopen allclose all
No evidence of erythema or edema was observed after each of the three induction exposures or at 24 or 48 h following the challenge dose.
Other observations: 8 out of 19 test animals showed slight patchy erythema at 24 h following the first challenge, and 15 animals showed a slight patchy erythema 24 h after the rechallenge.
9 out of 10 and 3 out of 10 negative control animals showed slight patchy erythema 24 hours after challenge and rechallenge respectively.
One animal in the treated group was found dead on day 20, the cause of which could not be determined. All other animals remained healthy and gained weight throughout the study.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a GLP study conducted according to OECD Guideline 406 and EU method B.6, trisodium EDDS was assessed for its sensitisation potential when applied to the skin of albino guinea pigs (modified Buehler method). Groups of ten guinea pigs of each sex were exposed to a 50% solution of the test substance for 6 h under an occluded patch applied to the clipped shoulder region, followed by two further exposures at 7-day intervals. After a 2-week recovery period, the animals were exposed to a 50% challenge dose and observed for skin reactions for 48 h. Groups of five animals of each sex were used as negative controls, receiving only the challenge dose. There was no evidence of positive skin reactions either after the induction exposures or after the challenge dose in any of the animals. No deaths occurred during the study and no clinical signs of toxicity or effects on body weight gain were seen (Arcelin, 1993c).
In a GLP study conducted according to a protocol similar to OECD Guideline 406, trisodium EDDS was assessed for its ability to induce skin sensitisation in albino guinea pigs (modified Buehler method). Groups of ten animals of each sex were placed in Buehler restrainers and exposed to an induction dose of 0.5 g of neat trisodium EDDS in an occluded Hilltop chamber for 6 h. The induction process was repeated 7 and 14 d later. After a further 14 d the treated animals and an untreated control group (5/sex) received a challenge dose of 0.5 g for 6 h. The test sites were scored for erythema and edema 24 and 48 h after patch removal. in addition, the test sites were rechallenged 7 d later. One animal in the treatment group showed slight confluent erythema 24-h after challenge application; all other animals in this group as well as the control group showed no reaction or slight patchy erythema at 24 and 48 h post challenge. The positive controls developed moderate to severe erythema demonstrating the validity of the study. One animal in the treatment group died on day 20 (prior to the challenge phase) from undetermined causes; all other animals remained healthy and gained in body weight throughout the study (Merriman, 1995).
In a GLP study, trisodium EDDS was assessed for its skin sensitising potential in a human repeat insult patch test. During the induction phase, a 5% solution was applied to the skin of the upper arm of more than 100 individuals for 24 h under an occluded patch on alternate working days over a three-week period (9 applications). Between 12-20 days after the last induction exposure, a challenge dose of 5% was applied under an occluded patch to the same area and as a control to a similar site on the other arm. The test areas were examined at 48 and 96 h after application of the challenge dose. No evidence of either irritation during the induction stage or of sensitisation after the challenge application was observed in any of the 111 individuals who completed the study (Rybicki, 1993).
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
There are no data relating to respiratory sensitisation in humans or laboratory animals. However, the lack of skin sensitisation potential in humans and guinea-pigs suggests that it would not possess the potential to cause such an effect.
Justification for classification or non-classification
According to EU CLP regulation, trisodium EDDS would not be classified as a skin or respiratory sensitiser under the conditions of the tests described
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.